Skip to main content
Clinical Trials/NCT06223945
NCT06223945
Active, not recruiting
Not Applicable

Surgical and Anesthesiological-resuscitation Aspects of Therapeutic Tactics for Thrombotic and Hemorrhagic Complications in Patients With the New Coronavirus Infection COVID-19

Volgograd State Medical University1 site in 1 country1 target enrollmentJanuary 12, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19 (Coronavirus Disease 2019)
Sponsor
Volgograd State Medical University
Enrollment
1
Locations
1
Primary Endpoint
development of an algorithm for the prevention of thrombohemorrhagic complications of COVID-19
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

The nature of the planned study:

The topic is of an applied nature and is aimed at improving the results of comprehensive treatment of patients with COVID-19, the course of whose disease was complicated by thrombotic or hemorrhagic catastrophes.

It is planned to analyze the results of treatment of this category of patients based on the work of several centers that provided surgical care to patients with COVID-19 during the pandemic (8 cities).

As a result of the analysis, it is planned to develop algorithms for the prevention and treatment of thrombotic and hemorrhagic complications in patients with COVID-19.

The proposed study will be multicenter, cohort, retrospective.

The purpose of the study:

Improvement of treatment results in COVID-19 patients with thrombotic or hemorrhagic complications

Scientific novelty:

For the first time, as a result of a multicenter study, it is expected to identify the most effective approach to the treatment and prevention of thrombotic and hemorrhagic complications in patients with COVID-19.

For the first time, it is planned to develop and put into practice algorithms for the application of the most effective methods of treatment and prevention of thrombohemorrhagic complications of COVID-19.

Registry
clinicaltrials.gov
Start Date
January 12, 2024
End Date
January 12, 2029
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Volgograd State Medical University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with thrombohemorrhagic complications who were treated in a covid hospital

Exclusion Criteria

  • Cancer patients
  • Patients who had thrombohemorrhagic disorders before admission to the hospital
  • Pregnant women
  • Patients receiving routine anticoagulant and antiplatelet therapy before admission to the hospital

Outcomes

Primary Outcomes

development of an algorithm for the prevention of thrombohemorrhagic complications of COVID-19

Time Frame: 5 years

It is planned to perform a multicenter cohort retrospective study with an expanded analysis of the clinical features of the course, the results of surgical treatment, intensive care, anesthesiological and resuscitation benefits in patients with COVID-19, the course of which was complicated by thrombotic and hemorrhagic complications, including internal and external bleeding from the hollow organs of the abdominal cavity, retroperitoneal space and chest. The material for the study will be formed by combining data from several large clinics, on the basis of which infectious diseases hospitals with a concentration of surgical patients have been deployed. Based on the cumulative assessment of the results obtained, new and improved previously developed surgical and anesthetic-resuscitation algorithms for diagnosis, surgical tactics, intensive care in patients with COVID-19 with thrombotic and hemorrhagic complications in need of surgical and resuscitation procedures will be proposed.

Study Sites (1)

Loading locations...

Similar Trials